top of page

Nucleic Acid Therapeutics: From Bench to Bedside

January 14–16, 2027 • The University of Hong Kong

Organising Institutes

The University of Hong Kong
Alnylam

The conference is jointly organised by three institutions, bridging excellence across research and industry.

BEACON of Peking University
Alnylam_Pharmaceuticals-Logo.wine.png
Peking_University_seal.svg.webp
beacon.png

Scientific Themes

Our programme is structured around four key scientific pillars, bridging the gap between fundamental research and clinical translation.

01
Nucleic Acid Biology and Chemistry

Exploring the latest breakthroughs in nucleic acid modifications, molecular interactions, and trafficking mechanisms.

02
Delivery Technologies

Advancing ligand-targeted delivery, lipid nanoparticles, and endosomal escape enhancers for improved efficacy.

03
Emerging Nucleic Acid Tech

Examining AI-driven nucleic acid design and novel RNA therapeutic modalities to catalyze next-generation treatments.

04
Clinical Development

Direct engagement with ongoing clinical trials and translational progress in the global oligonucleotide community.

02
Delivery Technologies

​Advancing ligand-targeted delivery, lipid nanoparticles, and endosomal escape enhancers for improved efficacy.

Speakers

A diverse assembly of leading industry scientists, academic researchers, and international pioneers dedicated to accelerating the clinical translation of nucleic acid therapeutics.

The University of Hong Kong

Lecture Theatre 1, 3 Sassoon Road, Hong Kong

January 14–16, 2027

Networking & Poster Sessions

The conference provides a dedicated platform for students and early-career researchers to engage directly with international visionaries. Our poster sessions and networking events are designed to catalyze new regional and international partnerships, fostering the next generation of scientific leaders through direct access to the global oligonucleotide therapeutics community.

bottom of page